bdrF2 of Lyme disease spirochetes is coexpressed with a series of cytoplasmic proteins and is produced specifically during early infection.
about
Rrp1, a cyclic-di-GMP-producing response regulator, is an important regulator of Borrelia burgdorferi core cellular functions.BB0238, a presumed tetratricopeptide repeat-containing protein, is required during Borrelia burgdorferi mammalian infection.Lyme disease: point/counterpoint.A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi.In vivo expression technology and 5' end mapping of the Borrelia burgdorferi transcriptome identify novel RNAs expressed during mammalian infection.Demonstration of cotranscription and 1-methyl-3-nitroso-nitroguanidine induction of a 30-gene operon of Borrelia burgdorferi: evidence that the 32-kilobase circular plasmids are prophagesDemonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.Identification of an antiparallel coiled-coil/loop domain required for ligand binding by the Borrelia hermsii FhbA protein: additional evidence for the role of FhbA in the host-pathogen interaction.Analysis of a growth-phase-regulated two-component regulatory system in the periodontal pathogen Treponema denticolaSelective binding of Borrelia burgdorferi OspE paralogs to factor H and serum proteins from diverse animals: possible expansion of the role of OspE in Lyme disease pathogenesis.Comparative analysis of the properties and ligand binding characteristics of CspZ, a factor H binding protein, derived from Borrelia burgdorferi isolates of human origin.The Hpk2-Rrp2 two-component regulatory system of Treponema denticola: a potential regulator of environmental and adaptive responses.Example of real-time quantitative reverse transcription-PCR (Q-RT-PCR) analysis of bacterial gene expression during mammalian infection: Borrelia burgdorferi in mouse tissues.
P2860
Q33745332-ECB7CAFA-5D5D-42E1-A97C-5B491CB53024Q34298733-E35F90BF-52C6-4F2C-9E33-F997677063CCQ36140640-55F634A4-E766-4872-8D91-13E802FD4F29Q36804305-EE83A990-CD60-4372-98FE-25345858C38DQ37649482-38D59571-8A22-4300-B17F-D405073CACEEQ39892227-CD6A6900-A32D-4703-B9A4-73220FF481B0Q40380026-036F50CA-159A-4FFB-A7F1-706195E5B817Q40426232-123B923D-3BC1-4366-8C74-EE34E5D6B3CBQ41840345-15CD0C5A-F0E0-46B2-8962-452843B1BCADQ41902649-942FC134-6945-42E4-BCF1-16EDDB9473C5Q42062445-78F296C2-55EE-4213-B319-E45661ABA7FBQ42070680-7242F318-F2AB-4CE7-9661-BC801ED0C121Q44723191-3B548989-F501-4F6B-87C2-6A2410D7A823
P2860
bdrF2 of Lyme disease spirochetes is coexpressed with a series of cytoplasmic proteins and is produced specifically during early infection.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
bdrF2 of Lyme disease spiroche ...... ically during early infection.
@ast
bdrF2 of Lyme disease spiroche ...... ically during early infection.
@en
bdrF2 of Lyme disease spiroche ...... ically during early infection.
@nl
type
label
bdrF2 of Lyme disease spiroche ...... ically during early infection.
@ast
bdrF2 of Lyme disease spiroche ...... ically during early infection.
@en
bdrF2 of Lyme disease spiroche ...... ically during early infection.
@nl
prefLabel
bdrF2 of Lyme disease spiroche ...... ically during early infection.
@ast
bdrF2 of Lyme disease spiroche ...... ically during early infection.
@en
bdrF2 of Lyme disease spiroche ...... ically during early infection.
@nl
P2093
P2860
P1476
bdrF2 of Lyme disease spiroche ...... ically during early infection.
@en
P2093
Abayami Raji
Hongming Zhang
Michael Theisen
Paul R Hansen
P2860
P304
P356
10.1128/JB.187.1.175-184.2005
P407
P577
2005-01-01T00:00:00Z